IBOGF (Universal Ibogaine) OCF Margin %: -15.77% (As of Apr. 2025)


What is Universal Ibogaine OCF Margin %?

Universal Ibogaine IBOGF -1.07% OCF Margin % is -15.77% as of Apr. 2025.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Universal Ibogaine's Cash Flow from Operations for the three months ended in Apr. 2025 was $-0.08 Mil. Universal Ibogaine's Revenue for the three months ended in Apr. 2025 was $0.50 Mil. Therefore, Universal Ibogaine's OCF Margin % for the quarter that ended in Apr. 2025 was -15.77%.

As of today, Universal Ibogaine's current OCF Yield % is -5.31%.

The historical rank and industry rank for Universal Ibogaine's OCF Margin % or its related term are showing as below:

IBOGF' s OCF Margin % Range Over the Past 10 Years
Min: -404.58   Med: -106.5   Max: -35.99
Current: -31.08

During the past 8 years, the highest OCF Margin % of Universal Ibogaine was -35.99%. The lowest was -404.58%. And the median was -106.50%.

IBOGF's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -64.23 vs IBOGF: -31.08

Universal Ibogaine OCF Margin % Related Terms

Universal Ibogaine OCF Margin % Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine OCF Margin % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -404.59 -106.41 -36.00

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -93.13 -15.20 -57.37 -54.05 -15.77

IBOGF vs LABT, CALC, LNAI: OCF Margin % Comparison

For the Biotechnology subindustry, Universal Ibogaine's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's OCF Margin % falls into.


Universal Ibogaine OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Universal Ibogaine's OCF Margin for the fiscal year that ended in Jul. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Jul. 2024 )/Revenue (A: Jul. 2024 )
=-0.612/1.7
=-36.00 %

Universal Ibogaine's OCF Margin for the quarter that ended in Apr. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Apr. 2025 )/Revenue (Q: Apr. 2025 )
=-0.079/0.501
=-15.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -15.77% mean?
Universal Ibogaine (IBOGF) has a OCF Margin % of -15.77% as of Apr. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Universal Ibogaine and its competitors.
Is Universal Ibogaine's OCF Margin % too high?
Universal Ibogaine's current OCF Margin % is -15.77%.
How does Universal Ibogaine's OCF Margin % compare to LABT and CALC?
Universal Ibogaine's OCF Margin % of -15.77% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Universal Ibogaine and its competitors. Universal Ibogaine's current OCF Margin % is -15.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current OCF Margin % of -15.77%. The current OCF Margin % is -15.77%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current OCF Margin % is -15.77% as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.